This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Chinese Academy of Sciences, Van Andel Research Institute. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3,364 
1 out of 26 
Years Active: 2025
Title: The Innovations of Mingliang Liu
Mingliang Liu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of small molecule agonists. His work focuses on creating compounds that can aid in the treatment of FXR-related diseases.
Latest Patents
Mingliang Liu holds a patent for an FXR small molecule agonist and its preparation method. This patent describes a compound with a specific structure, as shown in formula (I). The compound exhibits FXR agonistic activity, making it a potential candidate for drug development aimed at treating FXR-related diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Mingliang Liu has worked with esteemed institutions such as the Chinese Academy of Sciences and the Van Andel Research Institute. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Mingliang Liu has collaborated with notable colleagues, including Huaqiang Xu and Jia Tao Li. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.
Conclusion
Mingliang Liu's work in developing FXR small molecule agonists showcases his dedication to advancing medical science. His contributions have the potential to impact the treatment of various diseases, highlighting the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile